View More Recent Stories

Oct 21, 2024 07:06AM EF Hutton Starts NRx Pharmaceuticals, Inc. (NRXP) at Buy
Oct 3, 2024 06:56AM NRx Pharmaceuticals (NRXP) and HOPE Therapeutics to Acquire a Premier West Coast Interventional Psychiatric Clinic
Sep 30, 2024 07:07AM NRx Pharmaceuticals (NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100
Aug 26, 2024 07:56AM HOPE Therapeutics and NRx Pharmaceuticals (NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics
Aug 20, 2024 04:45PM NRx Pharmaceuticals (NRXP) Announces CEO Resignation
Aug 13, 2024 07:31AM NRx Pharmaceuticals (NRXP) Announces Up to $16M Secured Debt Financing from Anson Funds
Jul 29, 2024 08:36AM HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100
Jul 29, 2024 08:35AM HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NRXP) Announce Arbitration Order Enabling HOPE Therapeutics Spinoff
Jul 1, 2024 08:07AM NRx Pharmaceuticals (NRXP) Issues Shareholder Letter
Jun 28, 2024 08:07AM NRx Pharmaceuticals (NRXP) to Proceed with Two New Drug Applications in 2024, NRX-101 Returned to the Company for Filing
Jun 18, 2024 08:32AM NRx Pharmaceuticals (NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors
Jun 10, 2024 08:31AM NRx Pharmaceuticals (NRXP) Issues Shareholder Update Letter
View More Recent Stories